• OPEN AN ACCOUNT
Indian Indices
Nifty
26,027.30 -19.65
(-0.08%)
Sensex
85,213.36 -54.30
( -0.06%)
Bank Nifty
59,461.80 71.85
( 0.12%)
Nifty IT
38,386.30 111.55
( 0.29%)
Global Indices
Nasdaq
48,475.79 -249.23
(-0.51%)
Dow Jones
6,848.05 -73.95
(-1.07%)
Hang Seng
50,163.71 -672.84
(-1.32%)
Nikkei 225
9,761.09 112.06
(1.16%)
Forex
USD-INR
90.19 0.30
(0.34%)
EUR-INR
105.70 1.00
(0.96%)
GBP-INR
120.75 0.96
(0.80%)
JPY-INR
0.58 0.01
(0.91%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
44.97
888.1
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.2
 

aditya birla sun life crisil liquid overnight etf
Board of Godfrey Phillips India recommends interim dividend
Nov 04,2025
Godfrey Phillips India announced that the Board of Directors of the Company at its meeting held on 3 November 2025, inter alia, have recommended the interim dividend of Rs 17 per equity Share (i.e. 850%) , subject to the approval of the shareholders.